Comments on: Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2 http://www.xconomy.com/seattle/2009/07/28/dendreon-may-not-survive-its-success-qa-with-founder-chris-henney-part-2/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Gary Glass http://www.xconomy.com/seattle/2009/07/28/dendreon-may-not-survive-its-success-qa-with-founder-chris-henney-part-2/comment-page-1/#comment-72392 Gary Glass Tue, 28 Jul 2009 14:15:58 +0000 http://www.xconomy.com/?p=35101#comment-72392 Dendreon is truly a success story and an excellent investment for me and many others who believed in the science behind Provenge. Dendreon is truly a success story and an excellent investment for me and many others who believed in the science behind Provenge.

]]> By: Gloria Johnson http://www.xconomy.com/seattle/2009/07/28/dendreon-may-not-survive-its-success-qa-with-founder-chris-henney-part-2/comment-page-1/#comment-72383 Gloria Johnson Tue, 28 Jul 2009 12:04:16 +0000 http://www.xconomy.com/?p=35101#comment-72383 Thanks Luke for the excellent interview of Chris Henney and for your continued education of the public on the Dendreon story. It will be interesting to see what unfolds for Dendreon in the coming year: FDA approval of Provenge, ROW partnership, possible sale of the company. I look forward to your continued coverage. Thanks Luke for the excellent interview of Chris Henney and for your continued education of the public on the Dendreon story. It will be interesting to see what unfolds for Dendreon in the coming year: FDA approval of Provenge, ROW partnership, possible sale of the company. I look forward to your continued coverage.

]]>